<div id="readability-page-1"><ul><li>DocGo: A Growth Stock Going Higher In 2023</li></ul><p>DocGo Inc. (NASDAQ:DCGO - Free Report) - Northland Capmk reduced their Q3 2026 earnings per share (EPS) estimates for shares of DocGo in a research note issued on Monday, November 10th. Northland Capmk analyst M. Latimore now anticipates that the company will earn $0.00 per share for the quarter, down from their prior estimate of $0.03. The consensus estimate for DocGo's current full-year earnings is $0.25 per share. Northland Capmk also issued estimates for DocGo's Q4 2026 earnings at $0.00 EPS.</p><p>DocGo (NASDAQ:DCGO - Get Free Report) last announced its earnings results on Monday, November 10th. The company reported ($0.11) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.09) by ($0.02). DocGo had a negative net margin of 14.02% and a negative return on equity of 8.80%. The business had revenue of $70.81 million for the quarter, compared to analysts' expectations of $69.96 million.  DocGo has set its FY 2025 guidance at  EPS.</p><p>Several other research firms have also recently weighed in on DCGO. Zacks Research upgraded shares of DocGo from a &#34;strong sell&#34; rating to a &#34;hold&#34; rating in a research report on Thursday, November 6th. Canaccord Genuity Group  restated a &#34;buy&#34; rating on shares of DocGo in a report on Wednesday. Finally, Weiss Ratings  reaffirmed a &#34;sell (d)&#34; rating on shares of DocGo in a research report on Wednesday, October 8th. Two investment analysts have rated the stock with a Buy rating, four have issued  a Hold rating and one  has given a Sell rating to the stock. According to data from MarketBeat, DocGo  has an average rating of &#34;Hold&#34; and an average target price of $3.21.</p><p><b>Get Our Latest Stock Report on DCGO</b></p><h2>DocGo Price Performance</h2><p>DocGo stock opened at $1.10 on Wednesday. The business has a fifty day moving average price of $1.31 and a 200-day moving average price of $1.49. DocGo has a one year low of $0.97 and a one year high of $5.68. The firm has a market capitalization of $107.59 million, a P/E ratio of -2.12 and a beta of 0.93. </p><h2>Institutional Investors Weigh In On DocGo</h2><p>A number of institutional investors have recently added to or reduced their stakes in the stock. GSA Capital Partners LLP boosted its holdings in shares of  DocGo by 39.9% during the 3rd quarter. GSA Capital Partners LLP now owns 317,745 shares of the company's stock valued at $432,000 after purchasing an additional 90,571 shares during the last quarter.  JPMorgan Chase &amp; Co. lifted its position in shares of  DocGo by 92.0% in the third quarter. JPMorgan Chase &amp; Co. now owns 557,613 shares of the company's stock worth $758,000 after buying an additional 267,259 shares in the last quarter.  SG Americas Securities LLC boosted its stake in  DocGo by 23.5% during the third quarter. SG Americas Securities LLC now owns 169,174 shares of the company's stock valued at $230,000 after buying an additional 32,209 shares during the last quarter.  State of Wyoming grew its holdings in  DocGo by 113.3% during the 2nd quarter. State of Wyoming now owns 264,793 shares of the company's stock valued at $416,000 after buying an additional 140,670 shares in the last quarter.  Finally, Oxford Asset Management LLP raised its holdings in shares of  DocGo by 122.6% during the 2nd quarter. Oxford Asset Management LLP now owns 93,126 shares of the company's stock worth $146,000 after acquiring an additional 51,298 shares in the last quarter. 56.44% of the stock is owned by hedge funds and other institutional investors. </p><h2>DocGo Company Profile</h2> (Get Free Report)<p>DocGo Inc provides mobile health and medical transportation services for various health care providers in the United States and the United Kingdom. The company's transportation services include emergency response services; and non-emergency transport services comprise ambulance and wheelchair transportation services.</p><h2>Featured Stories</h2><ul><li>Five stocks we like better than DocGo</li><li>What Are Growth Stocks and Investing in Them </li><li>Occidental Petroleum is a Buy in Q4 2025</li><li>Overbought Stocks Explained: Should You Trade Them?</li><li>3 Beaten-Down Stocks With Rebound Potential This Earnings Season</li><li>Stock Dividend Cuts Happen Are You Ready?</li><li>Amazon Is One of the Clearest Buys If the Market Dips Again</li></ul> <p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/EarningsEstimatesChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9RENHTw?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" width="650" height="325" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/EarningsEstimatesChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9RENHTw"/></p><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p><h2>Should You Invest $1,000 in DocGo Right Now?</h2><p>Before you consider DocGo, you'll want to hear this.</p><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and DocGo wasn't on the list.</p><p>While DocGo currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.</p><p>View The Five Stocks Here</p>                  </div>

DCGO

<p>Northland Capmk has lowered its Q3 2026 EPS estimates for DocGo to $0.00 from $0.03. DocGo reported a Q3 EPS of ($0.11), missing consensus estimates. Analysts have mixed ratings on DocGo, with an average rating of "Hold" and a target price of $3.21. Institutional investors have adjusted their stakes in DocGo, which provides mobile health services in the US and UK.</p>

Northland Capmk Issues Negative Estimate for DocGo Earnings